Comparison of the Effects of Fentanyl, Oxycodone, Butorphanol on Gastrointestinal Function

Not Applicable

• Conditions: Endometrial Cancer; Cervix Neoplasms; Adenomyosis; Fibroid Uterus
• Interventions: Drug: the drug of intravenous patient-controlled analgesia

• Registration Number: NCT04295109
• Lead Sponsor: The First Affiliated Hospital with Nanjing Medical University

Brief Summary

Postoperative ileus (POI) is a transient loss of coordinated peristalsis precipitated by surgery and exacerbated by opioid pain medication.So,how to provide patients with ideal analgesia without affecting the recovery of postoperative gastrointestinal function?This was a prospective randomized controlled study. A total of 105 patients who were scheduled for laparoscopic hysterectomy were randomly selected from The First Affiliated Hospital with Nanjing Medical University by random number table. These patients were randomly divided into three groups: fentanyl(F) group, oxycodone(O) group and butorphanol(B) group.

Detailed Description

Background: Patients often experience pain after gynecological laparoscopy. However, the use of opioid analgesia after surgery may increase the incidence of postoperative ileus (POI). Postoperative ileus (POI) is a common surgical emergency after a surgical procedure, leading to infection and intestinal adhesions, which can extend hospitalization and increase readmission rates, and consequently increasing healthcare costs. How to provide patients with ideal analgesia without affecting the recovery of postoperative gastrointestinal function? There is no guideline which has been troubling clinical anesthesiologists.

Aims: To observe the effects of fentanyl, oxycodone, Butorphanol on the recovery of gastrointestinal function after laparoscopic hysterectomy.

Methods: A total of 105 patients undergoing laparoscopic hysterectomy were randomly divided to three groups: fentanyl group(group F), butorphanol group(group B), or oxycodone group(group O). The primary outcome measures were postoperative time to first anal exhaust the total analgesic doses in PCIA,effective bolus times. Patients were also assessed for pain with a visual analogue scale (VAS), the cumulative PCIA dose, adverse effects (Nausea,vomiting, bradycardia, respiratory depression and pruritus), sedation level at 4, 12, 24, and 48 hours postoperatively, and satisfaction during the postoperative 48 hours and postoperative hospitalization days.

Study Timeline

• Study First Submitted: 2020-01-05
• Study Start: 2020-03-02
• Study First Submitted QC: 2020-03-02
• Study First Posted: 2020-03-04
• Status Verified: 2020-04
• Last Update Submitted: 2020-04-21
• Last Update Posted: 2020-04-24
• Primary Completion: 2020-07-31
• Study Completion: 2020-07-31

Recruitment & Eligibility

• Status: UNKNOWN
• Sex: Female
• Target Recruitment: 105

Inclusion Criteria

1. patients who were scheduled for laparoscopic hysterectomy from W&C BRANCH HOSPITAL OF JIANGSU PROVINCE HOSPITAL
2. American Society of Anesthesiologists (ASA) physical status classification 1 to 2,
3. Women aged 40-65
4. Weight 50-80 kg

Exclusion Criteria

1. History of opioids abuse and allergy and contraindication to opioid drugs
2. bronchial asthma; coronary heart disease; severe hypertension; diabetes mellitus;
3. hepatic, and renal dysfunction (glutamyl aminotransferase> 40U or aspartate aminotransferase> 35U; urea nitrogen> 8.2 μmol / L, creatinine> 133 μmol / L),
4. History of brain damage or psychiatric disease
5. Patients with coagulopathy (PT> 17 seconds or activated partial thromboplastin time (APTT)> 47 seconds);
6. pregnant or lactating women;
7. Those with long-term constipation;
8. History of digestive diseases;
9. history of gastrointestinal disease (peptic ulcer disease, Crohn's disease, or ulcerative colitis)
10. Participants in other drug trials in the past three months. （11）After randomization and allocation, patients were withdrawn if laparoscopy was converted to open surgery or if they required reinvestigation for postoperative bleeding.

Study & Design

• Study Type: INTERVENTIONAL
• Study Design: PARALLEL

Arm && Interventions

Group	Intervention	Description
Oxycodone group(group O)	the drug of intravenous patient-controlled analgesia	Oxycodone hydrochloride injection, specification: 1mL: 10mg / branch (production unit: HAMOL LIMITED, valid period: 60 months) For group O patients,30mg oxycodone was mixed with saline to a total volume of 100mL; continuous infusion was set to 2mL/h, a bolus dose of 3mL, and a lockout interval of 15 minutes
Fentanyl group(group F)	the drug of intravenous patient-controlled analgesia	Fentanyl citrate injection, specification: 10mL: 0.5mg / piece (production unit: niching chang rendu Pharmaceutical Co., Ltd., valid period: 48 months) For group F patients,0.5mg fentanyl was mixed with saline to a total volume of 100mL; continuous infusion was set to 2mL/h, a bolus dose of 3mL, and a lockout interval of 15 minutes
Butorphanol group(group B)	the drug of intravenous patient-controlled analgesia	Butorphanol tartrate injection, specification: 1 mL: 1 mg / branch (production unit: Jiangsu henryi Pharmaceutical Co., Ltd., valid period: 24 months); For group B patients,10mg butorphanol was mixed with saline to a total volume of 100mL; continuous infusion was set to 2mL/h, a bolus dose of 3mL, and a lockout interval of 15 minutes

Primary Outcome Measures

Name	Time	Method
the cumulative dose administered in the patient-controlled mode	From date of operation until the date of first documented progression of anal exhaust , assessed up to 48 hours	The cumulative dose administered in the patient-controlled mode during the initial 48 hours after the operation was measured
postoperative time to first anal exhaust	From date of operation until the date of discharge from hospital or date of death from any cause, whichever came first, assessed up to 15 days	Timing from the end of the operation
effective bolus times	From date of operation until the date of first documented progression of anal exhaust , assessed up to 48 hours	The effective bolus times in the patient-controlled mode during the initial 48 hours after the operation was measured

Secondary Outcome Measures

Name	Time	Method
Sedation score	at 48 hours postoperatively	by using Ramsay scale（1=anxious and agitated or restless, or both; 2=cooperative, oriented, and tranquil; 3=responds to command only; 4=asleep, but has a brisk response to light tactile stimulus or a simple verbal command; 5=asleep, but arousable only by strong physical stimulus; and 6=asleep, unarousable）
adverse effects	at 48 hours postoperatively	Nausea 、vomiting 、bradycardia（HR \<60 beats min-1）、respiratory depression (According to practice guidelines from the ASA, clinical signs of opioid-induced respiratory depression are respiratory rate \<10 bpm, arterial O2 saturation \<90%, or arterial CO2 tension \>6.66 kPa)and pruritus
pain score	at 48 hours postoperatively	by using numerical rating scale (NRS):The pain scale ranged from 0 (=no pain) to 10 (=worst pain imaginable)
postoperative hospitalization days	From date of operation until the date of discharge from hospital or date of death from any cause, whichever came first, assessed up to 15 days	All patients were cured in accordance with clinical cure standard
patients' degree of overall satisfaction with the postoperative analgesia	at 48 hours postoperatively	Patients were asked to evaluate their degree of overall satisfaction with the postoperative analgesia on a 11-point scale (0= very unsatisfied, 1-3= unsatisfied, 4-6 = neutral, 7-9= satisfied, or 10 = very satisfied).

Trial Locations

Locations (1)

The First Affiliated Hospital with Nanjing Medical University; 🇨🇳 Nanjing, Jiangsu, China